logo

Efficacy of atomoxetine for the treatment of ADHD symptoms in patients with pervasive developmental disorders: A prospective, open-label study.

This page provides detailed information about this publication. Please click on any text which is underlined to find more information.


Authors
Alberto Fernández-Jaén, Daniel Martín Fernández-Mayoralas, Beatriz Calleja-Pérez, Nuria Muñoz-Jareño, María del Rosario Campos Díaz, Sonia López-Arribas
Title
Efficacy of atomoxetine for the treatment of ADHD symptoms in patients with pervasive developmental disorders: A prospective, open-label study.
Journal
Journal of Attention Disorders
Year
2013
Volume
17
Issue
6
Page(s)
pp. 497-505.
Abstract Link
Read Abstract (New Window)
Publication Format
Journal Article
Efficacy Study/Review
Yes
Scientific Validity
Peer-Reviewed, Open Trial
Keywords
Adolescent / Secondary School Age, Asperger Syndrome, Atomoxetine, Attention Deficit Hyperactivity Disorder, Attention/Concentration, Autism, Autistic Disorder, Child/Children, Hyperactivity, Impulsivity, Intervention, Medication, Pervasive Developmental Disorder (Not Otherwise Specified), Primary / Elementary School Age, Selective Noradrenaline Re-Uptake Inhibitor

Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.


Related Pages


Publications | Publications Database | Search Publications